Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis

NCT00764309 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb